Sandbox brain abscess: Difference between revisions
Jump to navigation
Jump to search
Created page with "==brain abscess== {| | valign=top | <div style="border-radius: 5px 5px 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow..." |
No edit summary |
||
Line 159: | Line 159: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Sulfadiazine]]: 1 gm po q6h if <60 kg, 1.5 gm po q6h if 60 kg | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Sulfadiazine]]: 1 gm po q6h if <60 kg, 1.5 gm po q6h if 60 kg | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Folinic acid]] 10–25 mg po qd | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Folinic acid]] 10–25 mg po qd | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | ''''' | | style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen(<small><small><small>for 4–6 wks after resolution of signs</small></small></small>)''''' | ||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Pyrimethamine]] 200 mg po qd then 75 mg/day po''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Folinic acid]] 10–25 mg po qd | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
| style=" | |||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[TMP | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Clindamycin]] 600 mg po IV q6h'''''<BR>''OR''<BR>▸ '''''[[TMP]]/[[SMX]] 5/25 mg/kg po qd or IV bid'''''<BR>''OR''<BR>▸ '''''[[Atovaquone]] 750 mg po q6h''''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Suppression therapy''''' | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | ''''' | |||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Pyrimethamine]] | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Sulfadiazine]]: 2-4 g po q6-12h'''''<BR>''PLUS''<BR>▸'''''[[Pyrimethamine]] 25-50 mg po qd'''''<BR>''PLUS''<BR>▸ '''''[[Folinic acid]] 10–25 mg po qd''''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | OR | |||
| style="font-size: 90% | |||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[TMP-SMX]] 5/25 mg/kg po or IV q12h for 30 days ''''' | |||
|- | |- | ||
|} | |} | ||
|} | |} | ||
|} | |} |
Revision as of 18:15, 27 January 2014
brain abscess
Brain Abscess ▸ Primary source ▸ Contiguous source ▸ Post-traumatic ▸ Post-surgical ▸ metastatic or cryptogenic ▸ Immunocompromised |
|